Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00222131 · ClinicalTrials.gov registry record · Phase 2
Inhibition of Gastric Acid is the Key to Satisfactory Relief of Symptoms With Esomeprazole in NUD Patients
A Phase 2 study, sponsored by University of Kansas Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 73
- Enrollment target
NCT00222131 is a Phase 2 study that has completed, run by University of Kansas Medical Center. The registered enrollment target is 73 participants.
The verdict
NCT00222131, a Phase 2 study, has completed, sponsored by University of Kansas Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 73 participants
- Enrollment target
Study Summary
Inhibition of gastric acid is the key to satisfactory relief of symptoms with esomeprazole in NUD patients
Interventions
- OTHER Placebo
- DRUG Esomeprazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2003-10 |
| Est. Completion | 2008-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00222131
The ClinicalTrials.gov registry entry for NCT00222131 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 73 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00222131 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00222131 about?
NCT00222131 is a clinical study titled "Inhibition of Gastric Acid is the Key to Satisfactory Relief of Symptoms With Esomeprazole in NUD Patients". Inhibition of gastric acid is the key to satisfactory relief of symptoms with esomeprazole in NUD patients
What is the current status of trial NCT00222131?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 73 participants. The study started on 2003-10. Estimated completion is 2008-01.
What interventions are being tested in trial NCT00222131?
The interventions under investigation include: Placebo (OTHER), Esomeprazole (DRUG).
Who is sponsoring clinical trial NCT00222131?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.